CD163 and neoplasm: CD8+ and CD163+ T cells in EAC: Cytotoxic (CD8+) T-cells are innate immune cells, which recognize tumor cells by their neoantigens through T-cell receptor (TCR) and MHC-I tumor neoantigen interaction.